Not finding it? Sign in to also search OpenAlex live.
-
Repeated versus single praziquantel dosing regimen in treatment of female genital schistosomiasis: a phase 2 randomised controlled trial showing no difference in efficacy2024 Frontiers in Tropical Diseases article Immunology and Microbiology Parasites and Host Interactions Open access
Louise Thomsen Schmidt Arenholt, Bodo Sahondra Randrianasolo, Tiana Onintsoa Oliva Rabozakandraina, Charles Émile Ramarokoto, Karoline Jøker, Katrina Kæstel Aarøe, +13 more
12citations -
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study2026 Journal of the American Academy of Dermatology article Immunology and Microbiology Mast cells and histamine Open access
Frank Siebenhaar, Sigurd Broesby‐Olsen, Mariana Castells, Tracy I. George, Cristina Bulai Livideanu, Iván Álvarez‐Twöse, +25 more
7citations -
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)2024 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Philipp Meyer-Wilmes, Jens Huober, Michael Untch, Jens‐Uwe Blohmer, Wolfgang Janni, Carsten Denkert, +18 more
6citations -
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study
Mattea Reinisch, Michael Untch, Rolf Mahlberg, Toralf Reimer, T Hitschold, Frederik Marmé, +18 more
5citations -
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA ‐ AF registry phase III2024 Diabetes Obesity and Metabolism article Medicine Atrial Fibrillation Management and Outcomes Open access
Yang Liu, Chen Yang, Steven Ho Man Lam, Bi Huang, Giulio Francesco Romiti, Uazman Alam, +5 more
3citations -
GAIN-2: Neo-/adjuvant phase III trial to compare intense dose-dense chemotherapy (CT) to tailored dose-dense CT in patients (pts) with high risk early breast cancer (EBC): Results on safety and interim invasive disease-free survival (iDFS).2020 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Volker Jochen Moebus, Hans-Joachim Lueck, Ekkehart Ladda, Peter Klare, Marcus Schmidt, Andreas Schneeweiß, +14 more
3citations -
A Phase 3, Multicenter, Randomized, Open-Label, Active Comparator Conversion Study of Roxadustat in Non-Dialysis-Dependent (NDD) Patients with Anemia in CKD2020 Journal of the American Society of Nephrology conference-abstract Medicine Erythropoietin and Anemia Treatment
Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Yusuke Yamaguchi
2citations -
Detection of Prostate Cancer Metastases During Pelvic Lymph Node Dissection with the PSMA-Targeted Fluorescent Agent OTL78: A Phase II Study2025 Molecular Imaging and Biology article Medicine Prostate Cancer Diagnosis and Treatment Open access cited by 2 patents
Judith A. Stibbe, Daan G. J. Linders, Robin A. Faber, Rob F. M. Bevers, Erik J. van Gennep, Stijn Crobach, +4 more
2citations -
Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial2025 BMJ Open article Pharmacology, Toxicology and Pharmaceutics Chemotherapy-induced organ toxicity mitigation Open access
Anouk V. M. Burger, Charlotte W. Duinkerken, Jeroen C. Jansen, Stijn Keereweer, Froukje L. J. Cals, Robert Jan Stokroos, +9 more
2citations -
2-deoxy-D-glucose in a human rhinovirus challenge model: A randomized, double-blind placebo-controlled phase 2a clinical trial2026 International Journal of Infectious Diseases article Medicine Respiratory viral infections research Open access
Victor M. Cnossen, Salma Assil, Marieke L de Kam, Meta Roestenberg, Anna-Dorothea Gorki, Ronald B. Turner, +2 more
0citations -
Impact of chronic obstructive pulmonary disease on the natural history of atrial fibrillation: a report from the GLORIA-AF registry phase II & III2023 European Heart Journal article Medicine Atrial Fibrillation Management and Outcomes Open access
Giulio Francesco Romiti, Marco Proietti, Bernadette Corica, Davide Antonio Mei, Freddy J. Frost, Arnaud Bisson, +5 more
0citations -
MON-LB55 Biochemical Control of Most Patients Reverting to Injectable Long-Acting Somatostatin Receptor Ligands Is Achieved After One Dose: Results From the Phase 3, Randomized, Double Blind, Placebo-Controlled Optimal Study2020 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access
Maria Fleseriu, Susan Leanne Samson, Lisa B. Nachtigall, Artak Labadzhyan, Atanaska P. Elenkova, William Henry Ludlam, +6 more
0citations -
Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic‐Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double‐Blind, Placebo‐Controlled APEX Study
Christopher T. Ritchlin, Philip J. Mease, Laura C. Coates, Alexa P. Kollmeier, Bei Zhou, Yusang Jiang, +7 more
0citations -
Atherosclerotic plaque iron accumulation characterizes a distinct phase of intra-plaque haemorrhage and is associated with inflammation and remodelling2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access
Elias B Wieland, Aniek Plug, Benjamin Balluff, Marion J. Gijbels, Lele Han, Bryn Flinders, +7 more
0citations -
[ 89 Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2 -related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial
Jules P. J. Douwes, Annemijn L. Tops, Petra Dibbets‐Schneider, Berit M. Verbist, Constanza Fuentealba Bassaletti, Kimberley S. Koetsier, +10 more
0citations -
OC 25.5 Kinetics of platelet response with ianalumab plus eltrombopag vs eltrombopag alone in patients with primary immune thrombocytopenia (ITP) treated in the second-line setting in the randomized, double-blind, phase 3 VAYHIT2 study2026 Research and Practice in Thrombosis and Haemostasis article Medicine Platelet Disorders and Treatments Open access
Francesco F. Zaja, Hanny T. Al-Samkari, Nichola Cooper, Martina Crysandt, Waleed Ghanima, Marc Michel, +7 more
0citations